Island Pharmaceuticals Statistics
Total Valuation
ASX:ILA has a market cap or net worth of AUD 123.80 million. The enterprise value is 116.93 million.
| Market Cap | 123.80M |
| Enterprise Value | 116.93M |
Important Dates
The last earnings date was Sunday, February 22, 2026.
| Earnings Date | Feb 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:ILA has 294.77 million shares outstanding. The number of shares has increased by 88.25% in one year.
| Current Share Class | 294.77M |
| Shares Outstanding | 294.77M |
| Shares Change (YoY) | +88.25% |
| Shares Change (QoQ) | +24.50% |
| Owned by Insiders (%) | 40.50% |
| Owned by Institutions (%) | 4.62% |
| Float | 149.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,969.77 |
| PB Ratio | 17.30 |
| P/TBV Ratio | 19.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -16.25 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.40
| Current Ratio | 8.40 |
| Quick Ratio | 8.21 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -130.31% and return on invested capital (ROIC) is -83.32%.
| Return on Equity (ROE) | -130.31% |
| Return on Assets (ROA) | -74.67% |
| Return on Invested Capital (ROIC) | -83.32% |
| Return on Capital Employed (ROCE) | -102.89% |
| Weighted Average Cost of Capital (WACC) | 4.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +162.50% in the last 52 weeks. The beta is 0.13, so ASX:ILA's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | +162.50% |
| 50-Day Moving Average | 0.42 |
| 200-Day Moving Average | 0.33 |
| Relative Strength Index (RSI) | 57.49 |
| Average Volume (20 Days) | 421,011 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:ILA had revenue of AUD 62,851 and -7.20 million in losses. Loss per share was -0.03.
| Revenue | 62,851 |
| Gross Profit | -1.99M |
| Operating Income | -7.36M |
| Pretax Income | -7.20M |
| Net Income | -7.20M |
| EBITDA | n/a |
| EBIT | -7.36M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 6.87 million in cash and n/a in debt, giving a net cash position of 6.87 million or 0.02 per share.
| Cash & Cash Equivalents | 6.87M |
| Total Debt | n/a |
| Net Cash | 6.87M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 7.16M |
| Book Value Per Share | 0.03 |
| Working Capital | 6.37M |
Cash Flow
| Operating Cash Flow | -3.67M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -11,715.94% |
| Pretax Margin | -11,452.57% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:ILA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -88.25% |
| Shareholder Yield | -88.25% |
| Earnings Yield | -5.81% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:ILA has an Altman Z-Score of 35.76 and a Piotroski F-Score of 1.
| Altman Z-Score | 35.76 |
| Piotroski F-Score | 1 |